# SWOG-9451, Combination Chemo & RT For Patients With Stage III/Stage IV Cancer of the Hypopharynx or Tongue

> **NCT00002735** · PHASE2 · TERMINATED · sponsor: **SWOG Cancer Research Network** · enrollment: 68 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** Induction chemotherapy
- **DRUG:** cisplatin
- **DRUG:** fluorouracil
- **RADIATION:** low-LET cobalt-60 gamma ray therapy

## Key facts

- **NCT ID:** NCT00002735
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1996-04
- **Primary completion:** 2004-04
- **Final completion:** 2005-03
- **Target enrollment:** 68 (ACTUAL)
- **Why stopped:** Terminated due to poor accrual.
- **Last updated:** 2015-09-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002735, "SWOG-9451, Combination Chemo & RT For Patients With Stage III/Stage IV Cancer of the Hypopharynx or Tongue". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00002735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*